<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC2017-2018_S13_ch12_p203-208</title>
		<link href="BCSC2017-2018_S13_ch12_p203-208-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC2017-2018_S13_ch12_p203-208" lang="en-US">
		<div id="_idContainer002" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter </span>12</p>
			<p class="chapter-title">Emerging Technologies</p>
			<p class="video-list-mid ParaOverride-1"><img class="_idGenObjectAttribute-1" src="data:image/png;base64,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" alt="" />&#9;This chapter includes a related video, which can be accessed by scanning the QR code provided in the text or going to www.aao.org/bcscvideo_section13.</p>
			<p class="body-text--no-indent-">Over the past 20&#160;years, a wide variety of surgical techniques and technologies have evolved to reduce dependence on contact lenses or glasses for use in routine daily activities. As a new frontier, the field of refractive surgery is expected to see continued innovation and progress. To give the reader a glimpse of the possible future, this chapter highlights some refractive surgical procedures that are not currently approved by the US Food and Drug Administation (FDA). These procedures include all-&#173;femtosecondlaser keratorefractive surgery as well as corneal crosslinking (CCL) for ectatic disorders combined with additional refractive intervention to achieve visual rehabilitation with greater spectacle and contact lens independence.</p>
			<p class="h1">Refractive Lenticule Extraction</p>
			<div id="Chapt12_Top1">
			<p class="body-text--no-indent-">In 1996, investigators first described the use of a picosecond laser to generate an intrastromal lenticule that was removed manually after the flap was lifted. The main drawbacks of this procedure, which was a precursor to modern refractive lenticule extraction (commonly referred to as ReLEx) were the relatively low precision and accuracy of the laser. In 1998, the first studies involving this technology were performed in rabbit eyes and in partially sighted eyes.</p>
			<p class="body-text">Following the debut of the VisuMax femtosecond laser (Carl Zeiss Meditec, Jena, Germany) in 2007, the intrastromal lenticule method was reintroduced in a procedure named femtosecond lenticule extraction (commonly referred to as FLEx) This procedure involved intrastromal dissection of a refractive lenticule as well as creation of a corneal flap and was performed exclusively by femtosecond laser. The refractive results were similar to those observed in laser in situ keratomileusis (LASIK), but the visual recovery time was longer.</p>
			<p class="body-text">More recently, a method called small-&#173;incision lenticule extraction (SMILE), has been developed. It is also a form of lenticule extraction but has the advantage of being performed entirely within a pocket, thereby avoiding the need for a flap. Conformité Européenne (CE) marking was achieved in 2009. It is currently awaiting FDA approval pending results in ongoing clinical trials.</p>
			<p class="reference-first">Blum M, Kunert KS, Engelbrecht C, Dawczynski J, Sekundo W. [Femtosecond lenticule extraction (FLEx)—results after 12&#160;months in myopic astigmatism]. <span class="italic">Klin Monbl Augenheilkd.</span> 2010;<br />227(12):961–965. German.</p>
			<p class="reference-mid">Krueger RR, Juhasz T, Gualano A, Marchi V. The picosecond laser for nonmechanical laser in situ keratomileusis. <span class="italic">J&#160;Refract Surg.</span> 1998;14(4):467–469.</p>
			<p class="reference-mid">Sekundo W, Kunert KS, Blum M. Small incision corneal refractive surgery using the small incision lenticule extraction (SMILE) procedure for the correction of myopia and myopic astigmatism: results of a 6-month prospective study. <span class="italic">Br&#160;J Ophthalmol.</span> 2011;95(3):<br />335–339.</p>
			<p class="reference-mid">Shah R, Shah S. Effect of scanning patterns on the results of femtosecond laser lenticule extraction refractive surgery. <span class="italic">J&#160;Cataract Refract Surg.</span> 2011;37(9):1636–1647.</p>
			<p class="reference-last--no-space-">Vestergaard A, Ivarsen A, Asp S, Hjortdal JØ. Femtosecond (FS) laser vision correction procedure for moderate to high myopia: a prospective study of ReLEx® FLEx and comparison with a retrospective study of FS-&#173;laser in situ keratomileusis. <span class="italic">Acta Ophthalmol.</span> 2013;91(4):<br />355–362.</p>
			<p class="h2">Indications and Preoperative Evaluation</p>
			<p class="body-text--no-indent-">The SMILE procedure is currently limited to use in myopic patients (up to –10.00&#160;D) with astigmatism up to 6.00&#160;D. Preoperative evaluation is similar to that for patients undergoing photoablative procedures, such as LASIK or photorefractive keratectomy (PRK); as in all refractive procedures involving tissue removal, a primary goal is to exclude patients with corneal ectatic diseases and susceptibility to postoperative ectasia.</p>
			<p class="reference-first">Ambrósio R Jr, Ramos I, Lopes B, et al. Ectasia susceptibility before laser vision correction. <span class="italic">J&#160;Cataract Refract Surg.</span> 2015;41(6):1335–1336.</p>
			<p class="reference-last--no-space-">Moshirfar M, McCaughey MV, Reinstein DZ, Shah R, Santiago-&#173;Caban L, Fenzl CR. Small-&#173;incision lenticule extraction. <span class="italic">J&#160;Cataract Refract Surg.</span> 2015;41(3):652–665.</p>
			<p class="h2">Surgical Technique</p>
			<p class="body-text--no-indent-">During SMILE, the femtosecond laser creates first the lower interface of the intrastromal lenticule (using an <span class="italic">out-to-in</span> direction, in order to minimize the length of time that the patient’s central vision is blurred), then the upper interface of the lenticule (using an <span class="italic">in-to-out</span> direction). The surgeon then makes a tunnel incision (usually superotemporal) measuring 2–3&#160;mm, connecting the cap interface to the corneal surface (Video&#160;12-1). The total time to generate the incisions is between 20 and 35&#160;seconds, regardless of the magnitude of the refractive error. A spatula is then inserted through the tunnel incision to separate residual lenticular attachments, first within the anterior lamella and then within the posterior plane. Once both planes have been separated, microforceps are used to extract the intrastromal lenticule.</p>
			<div class="_idGenObjectLayout-1">
				<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="data:image/jpg;base64,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" alt="" />
				</div>
			</div>
			<p class="QR-code-caption-first"><span class="QR-code-number">VIDEO 12-1</span> Small incision lenticule extraction procedure</p>
			<p class="QR-code-source">Courtesy of Renato Ambrósio Jr, MD, PhD.</p>
			<p class="QR-code-text-last">Scan the QR code or access Section 13 videos at www.aao.org/bcscvideo_section13.</p>
			<p class="reference-first">Ivarsen A, Asp S, Hjortdal J. Safety and complications of more than 1500 small-&#173;incision lenticule extraction procedures. <span class="italic">Ophthalmology.</span> 2014;121(4):822–828.</p>
			<p class="reference-mid">Moshirfar M, McCaughey MV, Reinstein DZ, Shah R, Santiago-&#173;Caban L, Fenzl CR. Small-&#173;incision lenticule extraction. <span class="italic">J&#160;Cataract Refract Surg.</span> 2015;41(3):652–665.</p>
			<p class="reference-last--no-space-">Reinstein DZ, Archer TJ, Gobbe M. Small incision lenticule extraction (SMILE) history, fundamentals of a new refractive surgery technique and clinical outcomes. <span class="italic">Eye Vis (Lond).</span> 2014 Oct&#160;16;1:3.</p>
			<p class="h2">Outcomes</p>
			<p class="body-text--no-indent-">Several studies have compared refractive outcomes of SMILE with those of LASIK. Overall, studies have shown that SMILE results are nearly identical to those of femtosecond laser–&#173;assisted LASIK. Currently, the disadvantage of SMILE is its slightly slower visual recovery on postoperative day&#160;1. In a study comparing SMILE with femtosecond laser–assisted LASIK, the uncorrected visual acuity (UCVA; also called <span class="italic">uncorrected distance visual acuity, UDVA</span>) in the LASIK group was at first statistically better than in the SMILE group, but at 6&#160;months, no difference in vision was observed between the 2&#160;groups. Incidentally, spherical aberration was lower in the SMILE group. Another study reported that 84% of eyes in each group achieved a UCVA of 20/20; however, 12% in the SMILE group and 4% in the LASIK group achieved a UCVA of 20/15. Higher-&#173;order aberrations, postoperative dry eye difficulty, and glare were significantly more common in the LASIK group.</p>
			<p class="reference-first ParaOverride-2">Ganesh S, Gupta R. Comparison of visual and refractive outcomes following femtosecond laser–&#173;assisted LASIK with SMILE in patients with myopia or myopic astigmatism. <span class="italic">J&#160;Refract Surg.</span> 2014;30(9):590–596.</p>
			<p class="reference-last--no-space-">Liu M, Chen Y, Wang D, et al. Clinical outcomes after SMILE and femtosecond laser–&#173;assisted LASIK for myopia and myopic astigmatism: a prospective randomized comparative study. <span class="italic">Cornea.</span> 2016;35(2):210–216.</p>
			<p class="h2">Complications</p>
			<p class="body-text--no-indent-">Studies have reported a low incidence of complications related to SMILE. Because the procedure can be technically challenging, most of the complications described in the literature occurred early in the learning curve. In a study enrolling 1800&#160;eyes treated with SMILE, perioperative complications included epithelial abrasions (occurring in 6.0% of eyes), difficult lenticule extraction (1.9%), small tears at the incision (1.8%), and cap perforation (0.22%); a major tear occurred in 1&#160;eye (0.06%). However, none of these patients reported late visual symptoms. Postoperative complications included trace haze (8.0%), epithelial dryness on postoperative day&#160;1 (5.0%), interface inflammation secondary to central abrasion (0.3%), and minor interface infiltrates (0.3%). Topographic irregular astigmatism was described in 1.0% of eyes, resulting in reduced 3-month best-&#173;corrected visual acuity (BCVA; also called <span class="italic">corrected distance visual acuity, CDVA</span>), or ghost images. Another complication unique to SMILE is the presence of a lenticule remnant in the interface. Postoperative ectasia has also been reported.</p>
			<p class="reference-first ParaOverride-2">Dong Z, Zhou X. Irregular astigmatism after femtosecond laser refractive lenticule extraction. <span class="italic">J&#160;Cataract Refract Surg.</span> 2013;39(6):952–954.</p>
			<p class="reference-last--no-space-">Ivarsen A, Asp S, Hjortdal J. Safety and complications of more than 1500&#160;small-&#173;incision lenticule extraction procedures. <span class="italic">Ophthalmology.</span> 2014;121(4):822–828.</p>
			<p class="h2">Re-treatment After SMILE</p>
			<p class="body-text--no-indent-">There are many options for performing re-&#173;treatments after SMILE. The choice is often dictated by the primary cap thickness and the availability of the technology. The cap may be converted into a flap and a thin-flap LASIK procedure may be performed. PRK may also be performed to re-treat SMILE patients.</p>
			<p class="reference-first ParaOverride-3">Riau AK, Ang HP, Lwin NC, Chaurasia SS, Tan DT, Mehta JS. Comparison of four different VisuMax circle patterns for flap creation after small incision lenticule extraction. <span class="italic">J&#160;Refract Surg.</span> 2013;29(4):236–244.</p>
			<p class="reference-last--no-space-">Zhao J, Yao P, Chen Z, et al. Enhancement of femtosecond lenticule extraction for visual symptomatic eye after myopia correction. <span class="italic">BMC Ophthalmol.</span> 2014 May&#160;18;14:68.</p>
			<p class="h2 ParaOverride-4">Comparison With LASIK</p>
			<p class="body-text--no-indent-">Because SMILE does not involve creation of a flap, the procedure has potential advantages over LASIK. Therefore, flap-&#173;related complications are avoided. In addition to reduced aberrations, dry eye difficulty, and glare, SMILE offers the relative preservation of biomechanical stability due to the absence of a flap and the maintenance of anterior stroma lamellae. The procedure may be particularly appropriate for patients who are involved in contact sports or high-risk professions.</p>
			</div>
			<p class="h1 ParaOverride-5">Corneal Crosslinking Plus Refractive Procedures</p>
			<div id="Chapt12_Top2">
			<p class="body-text--no-indent-">Corneal crosslinking (CCL) has been gaining popularity internationally as a first-line treatment for keratoconus and other ectatic disorders of the cornea (see Chapter&#160;7). However, the primary objective of the procedure is to stabilize a progressive ectatic condition; the patient will likely be relegated to using optical correction (glasses or contact lenses) to optimize visual acuity.</p>
			<p class="body-text">Visual rehabilitation of ectasia must achieve stabilization (using CCL) while reducing corneal irregularity and minimizing the residual refractive error. The term <span class="italic">corneal crosslinking plus</span> refers to CCL plus additional procedures such as PRK, phototherapeutic keratectomy (PTK), intracorneal ring segment (ICRS) implantation, conductive keratoplasty (CK), and phakic intraocular lens (PIOL) implantation.</p>
			<p class="reference-single--no-space- ParaOverride-3">Kymionis GD. Corneal collagen cross linking—plus. <span class="italic">Open Ophthalmol&#160;J.</span> 2011 Feb&#160;11;5:10. <br />doi:10.2174/1874364101105010010.</p>
			<p class="h2 ParaOverride-4">Photorefractive or Phototherapeutic Keratectomy and Corneal Crosslinking</p>
			<p class="body-text--no-indent-">Topography-&#173;guided PRK (T-PRK) may be performed either after CCL or simultaneously. One study showed that same-day simultaneous T-PRK and CCL is superior to sequential CCL and T-PRK beyond 6&#160;months. It is believed that CCL followed by T-PRK 6&#160;months later would remove the stiffened crosslinked cornea, thereby reducing the benefits of CCL; thus, simultaneous T-PRK and CXL is preferred. Similarly, another study demonstrated significant improvement in mean spherical equivalent refraction, defocus aberration, UCVA and BCVA, and keratometric parameters in patients undergoing simultaneous T-PRK and CCL.</p>
			<p class="body-text">The primary variables in combined T-PRK and CXL are the maximal ablation depth and the postoperative corneal thickness. Most surgeons choose a maximum ablation depth of 50&#160;µm and a minimal postoperative corneal thickness of 350–400&#160;µm. Although some surgeons advocate the use of mitomycin&#160;C 0.02% to prevent haze, others believe that it is not necessary.</p>
			<p class="body-text">In patients with keratoconus, the epithelium is not uniform in thickness; rather, it is thinner directly above the cone. Therefore, manual removal of the epithelium over the central 6–8&#160;mm will “unmask” the corneal stromal irregularity. In contrast, transepithelial PTK has the advantage of removing the thinned epithelium, Bowman layer, and stroma over the cone apex. Thus, the procedure may be able to regularize the anterior corneal surface while allowing the patient’s epithelium to act as a masking agent.</p>
			<p class="reference-first ParaOverride-2">Kanellopoulos AJ. Comparison of sequential vs same-day simultaneous collagen cross-&#173;linking and topography-&#173;guided PRK for treatment of keratoconus. <span class="italic">J&#160;Refract Surg.</span> 2009;<br />25(9):S812–S818.</p>
			<p class="reference-mid">Kymionis GD, Kontadakis GA, Kounis GA, et al. Simultaneous topography-&#173;guided PRK followed by corneal collagen cross-&#173;linking for keratoconus. <span class="italic">J&#160;Refract Surg.</span> 2009;25(9):<br />S807–S811.</p>
			<p class="reference-last--no-space-">Stojanovic A, Zhang J, Chen X, Nitter TA, Chen S, Wang Q. Topography-&#173;guided transepithelial surface ablation followed by corneal collagen cross-&#173;linking performed in a single combined procedure for the treatment of keratoconus and pellucid marginal degeneration. <span class="italic">J&#160;Refract Surg.</span> 2010;26(2):145–152.</p>
			<p class="h2 ParaOverride-6">Intracorneal Ring Segment Implantation and Corneal Crosslinking</p>
			<p class="body-text--no-indent-">Although ICRS implantation flattens the cone and regularizes the corneal topography, the procedure might not halt the progression of the ectatic process. Combining ICRS implantation and CCL may achieve both goals, however. Variations in technique relate to the number of segments used, the location of the segments, and the timing of the procedures.</p>
			<p class="body-text">One study reported that inferior-&#173;segment Intacs (Addition Technology, Lombard, IL) implantation with CCL resulted in better keratoconus improvement than Intacs implantation alone. Another study demonstrated that ICRS implantation followed by CCL resulted in better outcomes than CCL followed by ICRS.</p>
			<p class="reference-first ParaOverride-2">Chan CC, Sharma M, Wachler BS. Effect of inferior-&#173;segment Intacs with and without C3-R on keratoconus. <span class="italic">J&#160;Cataract Refract Surg.</span> 2007;33(1):75–80.</p>
			<p class="reference-last--no-space-">Coskunseven E, Jankov MR 2nd, Hafezi F, Atun S, Arslan E, Kymionis GD. Effect of treatment sequence in combined intrastromal corneal rings and corneal collagen crosslinking for keratoconus. <span class="italic">J&#160;Cataract Refract Surg.</span> 2009;35(12):2084–2091.</p>
			<p class="h2 ParaOverride-6">Phakic Intraocular Lens Implantation and Corneal Crosslinking</p>
			<p class="body-text--no-indent-">Several reports have demonstrated the benefits of PIOL implantation in conjunction with CCL. In patients with keratoconus, toric posterior chamber PIOLs and foldable iris-claw PIOLs both have shown improved refractive outcomes with good safety (no loss of BCVA and no significant decrease in endothelial cell count). Neither of these PIOLs has been approved by the US FDA.</p>
			<p class="reference-single">Kymionis GD, Grentzelos MA, Portaliou DM, et al. Corneal collagen cross-&#173;linking (CXL) combined with refractive procedures for the treatment of corneal ectatic disorders: CXL plus. <span class="italic">J&#160;Refract Surg.</span> 2014;30(8):566–576.</p>
		</div>
		</div>
	</body>
</html>
